Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 3
2005 1
2006 2
2007 1
2008 1
2009 1
2010 3
2011 1
2012 5
2013 3
2014 1
2015 2
2016 3
2017 6
2018 7
2019 7
2020 9
2021 9
2022 11
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
Incident diabetes in course of antiretroviral therapy.
Taramasso L, Squillace N, Ricci E, Menzaghi B, Orofino G, Socio GV, Molteni C, Martinelli CV, Madeddu G, Vichi F, Valsecchi L, Celesia BM, Maggi P, Rusconi S, Pellicanò GF, Cascio A, Sarchi E, Gulminetti R, Falasca K, Di Biagio A, Bonfanti P; CISAI Study Group. Taramasso L, et al. Among authors: vichi f. AIDS. 2023 Jul 1;37(8):1269-1276. doi: 10.1097/QAD.0000000000003548. Epub 2023 Mar 14. AIDS. 2023. PMID: 36927963
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity.
Fallerini C, Picchiotti N, Baldassarri M, Zguro K, Daga S, Fava F, Benetti E, Amitrano S, Bruttini M, Palmieri M, Croci S, Lista M, Beligni G, Valentino F, Meloni I, Tanfoni M, Minnai F, Colombo F, Cabri E, Fratelli M, Gabbi C, Mantovani S, Frullanti E, Gori M, Crawley FP, Butler-Laporte G, Richards B, Zeberg H, Lipcsey M, Hultström M, Ludwig KU, Schulte EC, Pairo-Castineira E, Baillie JK, Schmidt A, Frithiof R; WES/WGS Working Group Within the HGI; GenOMICC Consortium; GEN-COVID Multicenter Study; Mari F, Renieri A, Furini S. Fallerini C, et al. Hum Genet. 2022 Jan;141(1):147-173. doi: 10.1007/s00439-021-02397-7. Epub 2021 Dec 10. Hum Genet. 2022. PMID: 34889978 Free PMC article.
Lipids and transaminase elevations in ARV-experienced PLWH switching to a doravirine-based regimen from rilpivirine or other regimens.
Maggi P, Ricci ED, Cicalini S, Pellicanò GF, Celesia BM, Vichi F, Cascio A, Sarchi E, Orofino G, Squillace N, Madeddu G, De Socio GV, Bargiacchi O, Molteni C, Masiello A, Saracino A, Menzaghi B, Falasca K, Taramasso L, Di Biagio A, Bonfanti P. Maggi P, et al. Among authors: vichi f. BMC Infect Dis. 2023 Apr 14;23(1):227. doi: 10.1186/s12879-023-08191-2. BMC Infect Dis. 2023. PMID: 37059996 Free PMC article.
Lipids and Transaminase in Antiretroviral-Treatment-Experienced People Living with HIV, Switching to a Doravirine-Based vs. a Rilpivirine-Based Regimen: Data from a Real-Life Setting.
Maggi P, Ricci ED, Martinelli CV, De Socio GV, Squillace N, Molteni C, Masiello A, Orofino G, Menzaghi B, Bellagamba R, Vichi F, Celesia BM, Madeddu G, Pellicanò GF, Carleo MA, Cascio A, Parisini A, Taramasso L, Valsecchi L, Calza L, Rusconi S, Sarchi E, Martini S, Bargiacchi O, Falasca K, Cenderello G, Ferrara S, Di Biagio A, Bonfanti P; CISAI Study Group. Maggi P, et al. Among authors: vichi f. Viruses. 2023 Jul 23;15(7):1612. doi: 10.3390/v15071612. Viruses. 2023. PMID: 37515298 Free PMC article.
Sterol metabolism modulates susceptibility to HIV-1 Infection.
Saulle I, Ibba SV, Vittori C, Fenizia C, Mercurio V, Vichi F, Caputo SL, Trabattoni D, Clerici M, Biasin M. Saulle I, et al. Among authors: vichi f. AIDS. 2020 Sep 1;34(11):1593-1602. doi: 10.1097/QAD.0000000000002591. AIDS. 2020. PMID: 32501835 Free article.
High HIV-1 diversity in immigrants resident in Italy (2008-2017).
Maggiorella MT, Sanarico N, Brindicci G, Monno L, Santoro CR, Coppola N, Cuomo N, Azzurri A, Cesario F, Luciani F, El-Hamad I, D'Ettorre G, Turriziani O, Mazzuti L, Poggi A, Vichi F, Mariabelli E, Surace L, Berardelli G, Picconi O, Cenci A, Sernicola L, Rovetto C, Fulgenzi D, Belli R, Salvi E, Zeo PD, Borsetti A, Ridolfi B, Losappio R, Zoboli F, Schietroma I, Cella E, Angeletti S, Ciccozzi M, D'Amato S, Ensoli B, Buttò S; Italian Network for HIV Characterization. Maggiorella MT, et al. Among authors: vichi f. Sci Rep. 2020 Feb 24;10(1):3226. doi: 10.1038/s41598-020-59084-2. Sci Rep. 2020. PMID: 32094387 Free PMC article.
Leronlimab (PRO 140) in vitro activity against 4-class drug resistant HIV-1 from heavily treatment experienced subjects.
Rusconi S, Saladini F, Bellocchi MC, Galli L, Gagliardini R, Gazzola L, Francisci D, Vichi F, Focà E, Zazzi M, Santoro MM, Gabrieli A, Castagna A; PRESTIGIO Registry study group; PRESTIGIO Registry Steering Committee: Antonella Castagna (coordinator); Stefano Bonora; Leonardo Calza; Antonella Castagna; Giovanni Cenderello; Adriana Cervo; Giulio Maria Corbelli; Antonio Di Biagio; Emanuele Focà; Roberta Gagliardini; Laura Galli; Riccardo Lolatto; Franco Maggiolo; Giulia Marchetti; Stefano Rusconi; Maria Santoro; Vincenzo Spagnuolo; Katia Sterrantino; Maurizio Zazzi. Rusconi S, et al. Among authors: vichi f. Pharmacol Res. 2022 Feb;176:106064. doi: 10.1016/j.phrs.2022.106064. Epub 2022 Jan 6. Pharmacol Res. 2022. PMID: 34999223 No abstract available.
69 results